Table 1 Clinical Characteristics
Total (N = 373) | TAVR (n = 233) | No TAVR (n = 140) | P-value | |
|---|---|---|---|---|
DEMOGRAPHICS | ||||
Age, years | 82.4 ± 6.6 | 81.4 ± 6.3 | 84 ± 6.6 | < 0.001 |
Female sex | 184 (49%) | 108 (46%) | 76 (54%) | 0.14 |
Body Mass Index, kg/m2 | 27.1 ± 6 | 27.4 ± 6.1 | 26.3 ± 5.7 | 0.12 |
COMORBIDITIES | ||||
Diabetes mellitus | 80 (21%) | 66 (28%) | 14 (10%) | < 0.001 |
Coronary artery disease | 196 (53%) | 137 (59%) | 59 (42%) | 0.002 |
Prior myocardial infarction | 38 (10%) | 26 (11%) | 12 (9%) | 0.42 |
Prior stroke | 19 (5%) | 17 (7%) | 2 (1%) | 0.01 |
Peripheral arterial disease | 24 (6%) | 19 (8%) | 5 (4%) | 0.08 |
Chronic kidney disease | 187 (50%) | 104 (45%) | 83 (59%) | 0.006 |
Dialysis-dependent | 7 (2%) | 5 (2%) | 2 (2%) | 0.85 |
Cirrhosis | 7 (2%) | 5 (2%) | 2 (1%) | 0.62 |
NYHA class | 2.5 ± 0.6 | 2.4 ± 0.6 | 2.5 ± 0.7 | 0.15 |
ECHOCARDIOGRAM | ||||
LVEF ≤35% | 34 (9%) | 15 (7%) | 19 (14%) | 0.02 |
PASP ≥60 mmHg | 50 (13%) | 27 (12%) | 23 (16%) | 0.18 |
Mean aortic gradient, mmHg | 49.5 ± 18.3 | 52 ± 17.7 | 45.4 ± 18.6 | < 0.001 |